Pharmacogenomics study shows link between testing and better health outcomes

By Kate McCaffery | Sept. 24, 2020, 9:37 a.m.

Photo: Freepik

“The question we were trying to answer was if clinicians are provided access to pharmacogenomic test results during routine clinical care, would patient outcomes improve?”

This article is reserved to PRO Level subscribers

Discover the PRO Level

The most popular in Health

Beneva drops prescription requirements to soothe physicians

Ontario pharmacists can now prescribe for minor ailments

Insurers still hesitant to consider chronic pain as a disease

Headlines

Hub Financial acquires BridgeForce

Sun Life sells sponsored markets business, buys stake in U.S. distribution

Association’s new president outlines priorities for 2023

Related topics …

HBM+

Biologics weigh on group plans

Green Shield seeking to become the main care provider in Canada

Green Shield study confirms benefits of pharmacogenomic testing

Green Shield harnesses artificial intelligence to detect and prevent benefits fraud

GREEN SHIELD CANADA

Most popular articles of 2022 related to health

Telemedicine: Provider-insurer partnerships multiplying

Beneva supports gender transition in group insurance

Disability claims due to mental health issues on the rise

Medication

Mental health drugs and paramedical claims skyrocket

Cost of employer medical benefits forecast to rise 7.5 per cent in 2023

Ontario pharmacists can now prescribe for minor ailments

Ontario expands use of biosimilar drug treatments

Magazine supplement

Brokers concerned about cyber security

Table: 2021 Market shares of life and health insurers in Canada

Voluntary group critical illness insurance makes a breakthrough

Inflation continues to fuel travel insurance concerns

Pharmacogenomics study shows link between testing and better health outcomes

Choose your payment method

Confirmation